Yesterday, Feb. 1, 2016, 23 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $653.25 to $319,060,000.00.

Highlighted Stocks Traded by Insiders:

Polaris Industries (PII) - FREE Research Report

Kingsley Lawrence D, who is Director at Polaris Industries, bought 6,925 shares at $72.00 on Feb. 1, 2016. Following this transaction, the Director owned 6,925 shares meaning that the stake was boosted by 100% with the 6,925-share transaction.

The shares most recently traded at $75.92, up $3.92, or 5.16% since the insider transaction. Historical insider transactions for Polaris Industries go as follows:

  • 4-Week # shares sold: 20,000
  • 12-Week # shares sold: 20,000
  • 24-Week # shares sold: 28,429

The average volume for Polaris Industries has been 1.5 million shares per day over the past 30 days. Polaris Industries has a market cap of $4.8 billion and is part of the consumer goods sector and automotive industry. Shares are down 12.54% year-to-date as of the close of trading on Monday.

Polaris Industries Inc., together with its subsidiaries, designs, engineers, manufactures, and markets off-road vehicles, snowmobiles, motorcycles, and small vehicles primarily in the United States, Canada, Western Europe, Australia, and Mexico. The stock currently has a dividend yield of 2.87%. The company has a P/E ratio of 10.9. Currently, there are 10 analysts who rate Polaris Industries a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PII - FREE

TheStreet Quant Ratings

rates Polaris Industries as a

hold

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, poor profit margins and weak operating cash flow. Get the full

Polaris Industries Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Novavax (NVAX) - FREE Research Report

Erck Stanley C, who is CEO and President at Novavax, bought 2,072 shares at $4.38 on Feb. 1, 2016. Following this transaction, the CEO and President owned 103,057 shares meaning that the stake was boosted by 2.05% with the 2,072-share transaction.

Trizzino John, who is SVP, Commercial Operations at Novavax, bought 5,855 shares at $3.63 on Feb. 1, 2016. Following this transaction, the SVP, Commercial Operations owned 39,564 shares meaning that the stake was boosted by 17.37% with the 5,855-share transaction.

The shares most recently traded at $4.84, up $1.21, or 25% since the insider transaction. Historical insider transactions for Novavax go as follows:

  • 4-Week # shares bought: 11,463
  • 4-Week # shares sold: 27,945
  • 12-Week # shares bought: 11,463
  • 12-Week # shares sold: 27,945
  • 24-Week # shares bought: 11,463
  • 24-Week # shares sold: 76,601

The average volume for Novavax has been 6.3 million shares per day over the past 30 days. Novavax has a market cap of $1.4 billion and is part of the health care sector and drugs industry. Shares are down 39.93% year-to-date as of the close of trading on Monday.

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Currently, there are 6 analysts who rate Novavax a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NVAX - FREE

TheStreet Quant Ratings

rates Novavax as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

Novavax Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Northern Oil & Gas (NOG) - FREE Research Report

Rowling Robert B., who is 10% Owner at Northern Oil & Gas, bought 455,601 shares at $3.14 on Feb. 1, 2016. Following this transaction, the 10% Owner owned 10.1 million shares meaning that the stake was boosted by 4.72% with the 455,601-share transaction.

The shares most recently traded at $2.94, down $0.20, or 6.78% since the insider transaction. Historical insider transactions for Northern Oil & Gas go as follows:

  • 4-Week # shares bought: 1.9 million
  • 4-Week # shares sold: 355,771
  • 12-Week # shares bought: 3.4 million
  • 12-Week # shares sold: 355,771
  • 24-Week # shares bought: 3.4 million
  • 24-Week # shares sold: 355,771

The average volume for Northern Oil & Gas has been 1.6 million shares per day over the past 30 days. Northern Oil & Gas has a market cap of $207.8 million and is part of the basic materials sector and energy industry. Shares are down 20.47% year-to-date as of the close of trading on Monday.

Northern Oil and Gas, Inc., an independent energy company, engages in the acquisition, exploration, development, and production of oil and natural gas properties in the United States. Currently, there are 2 analysts who rate Northern Oil & Gas a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NOG - FREE

TheStreet Quant Ratings

rates Northern Oil & Gas as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Northern Oil & Gas Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.